Literature DB >> 32148470

Are Payments to Human Research Subjects Ethically Suspect?

David B Resnik1.   

Abstract

Bioethicists and institutional review boards often worry that paying human subjects too much money for research participation might compromise informed consent by coercing or unduly influencing individuals to enroll in studies against their better judgment. However, empirical research does not support the hypothesis that payments adversely impact judgment and decision-making concerning research participation, and the opposite problem - underpayment - also raises significant ethical concerns, such as exploitation, and under-enrollment. In this article, I argue that our ethical qualms about the negative impact of money on decisions concerning research participation are largely unfounded and reflect more general concerns about the need to avoid repeating abuses of human subjects that occurred in the past. I shall also argue that the best way to promote the rights and welfare of human research subjects is to treat them as competent adults who have the capacity to make wise choices involving money. What this argument means in practice is that offering human subjects money for their participation should not be regarded as ethically suspect, absent substantial evidence to the contrary.

Entities:  

Year:  2019        PMID: 32148470      PMCID: PMC7059779     

Source DB:  PubMed          Journal:  J Clin Res Best Pract


  38 in total

Review 1.  Money for research participation: does in jeopardize informed consent?

Authors:  C Grady
Journal:  Am J Bioeth       Date:  2001       Impact factor: 11.229

2.  Participation as commodity, participation as gift.

Authors:  T Chambers
Journal:  Am J Bioeth       Date:  2001       Impact factor: 11.229

3.  Concealment and fabrication by experienced research subjects.

Authors:  Eric G Devine; Megan E Waters; Megan Putnam; Caitlin Surprise; Katie O'Malley; Courtney Richambault; Rachel L Fishman; Clifford M Knapp; Elissa H Patterson; Ofra Sarid-Segal; Chris Streeter; Laurie Colanari; Domenic A Ciraulo
Journal:  Clin Trials       Date:  2013-07-18       Impact factor: 2.486

Review 4.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

5.  Subversive subjects: rule-breaking and deception in clinical trials.

Authors:  Rebecca Dresser
Journal:  J Law Med Ethics       Date:  2013       Impact factor: 1.718

6.  Deception by Research Participants.

Authors:  David B Resnik; David J McCann
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

7.  A national registry for healthy volunteers in phase 1 clinical trials.

Authors:  David B Resnik; Greg Koski
Journal:  JAMA       Date:  2011-03-15       Impact factor: 56.272

8.  Paying people to participate in research: why not? A response to Wilkinson and Moore.

Authors:  Paul McNeill
Journal:  Bioethics       Date:  1997-10       Impact factor: 1.898

9.  Bioethical Issues in Providing Financial Incentives to Research Participants.

Authors:  David B Resnik
Journal:  Medicoleg Bioeth       Date:  2015-06-24

10.  Association Between Financial Incentives and Participant Deception About Study Eligibility.

Authors:  Holly Fernandez Lynch; Steven Joffe; Harsha Thirumurthy; Dawei Xie; Emily A Largent
Journal:  JAMA Netw Open       Date:  2019-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.